Ipamorelin: selective GHS-R1a agonist minimal cortisol, prolactin, or appetite effects GHRP-6: GHS-R1a agonist with additional CRH/ACTH activation, prolactin release, and potent orexigenic activity Ipamorelin selectivity ratio (GH:cortisol) is among the highest of all synthetic GHRPs GHRP-6 was instrumental in GHS-R1a receptor identification but is pharmacologically non-selective GH Release Profiles & Pulse Amplitude Both ipamorelin and GHRP-6 stimulate pulsatile GH release from anterior pituitary somatotrophs via GHS-R1a activation, working synergistically with endogenous GHRH
Glutathione directly supports immune cell proliferation and function, enhancing the body's ability to defend against pathogens, viruses, and inflammatory triggers
Neutrophil extracellular traps: villains and targets in arterial, venous, and Cancer-Associated thrombosis
[Read More]
Many of the appearance-related changes people associate with GLP-1 drugs like Ozempic and Wegovy, however, are less about the medications themselves than the rapid weight loss they often produce